Guest Editor: Dr. Kazuhiro Ikegame

Allogeneic stem cell transplantation is a prototype of immunotherapy. Learning from the transplant experience, a variety of cell therapies has been developed and applied for various disorders. In this focused issue on "Stem Cell Transplantation and Cell Therapy", the excellent authorities reviewed their field including updated topics. We would like this issue a fruitful one.

Review Article  

Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients

Naoki Hosen, Tetsuo Maeda, Yoshiko Hashii, Akihiro Tsuboi, Sumiyuki Nishida, Jun Nakata, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama

PDF HTML

Hypomethylating agents after allogeneic blood stem cell transplantation

Thomas Schroeder, Christina Rautenberg, Rainer Haas, Guido Kobbe

PDF HTML

Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma

Shigeo Fuji, Takero Shindo

PDF HTML

Immune checkpoint blockade for hematologic malignancies: a review

Matthew J. Pianko, Yuzhou Liu, Srishti Bagchi, Alexander M. Lesokhin

PDF HTML

Short Report  

Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

Nicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, Per Thor Straten, Inge Marie Svane, Mads Hald Andersen, Lene Meldgaard Knudsen

PDF HTML